Abstract

Polycystic ovary syndrome (PCOS) represents a common endocrine—metabolic disorder disease with chronic low-grade inflammation and alteration of intestinal flora. Serving as functional food, flaxseed oil (FO), which is rich in plant-derived α-linolenic acid of omega-3 polyunsaturated fatty acids, has been proven to benefit for chronic metabolic diseases. However, the exact role of dietary FO on PCOS remains largely unclear. In the present study, 6-week-old female Sprague–Dawley rats were randomly divided into four groups (eight rats/group), including (a) pair-fed (PF) control (CON) group (PF/CON), (b) FO-fed CON group (FO/CON), (c) PF with letrozole-induced PCOS model (MOD) group (PF/MOD), and (d) FO-fed MOD group (FO/MOD). All rats were fed a standard diet. After 3 weeks of modeling and subsequent 8 weeks of treatment, the rats in diverse groups were euthanized and associated indications were investigated. The results showed that dietary FO ameliorated the disorder of estrous cycle and ovarian morphology. In parallel, dietary FO improved the sex steroid hormone disturbance (luteinizing hormone/follicle-stimulating hormone, estrogen, testosterone, and progesterone), body weights, dyslipidemia, and insulin resistance. Moreover, FO treatment improved plasma and ovary inflammatory interleukin (IL)-1β, IL-6, IL-10, and IL-17A, tumor necrosis factor-α, and monocyte chemoattractant protein-1. Additionally, FO intervention significantly modulated the composition of gut microbiota and vaginal microbiota by increasing the abundances of Allobaculum, Lactobacillus, Butyrivibrio, Desulfovibrio, Bifidobacterium, Faecalibacterium, Parabacteroides as well as decreasing the abundances of Actinobacteria, Bacteroides, Proteobacteria, and Streptococcus, the ratio of Firmicutes/Bacteroidetes. A decrease in plasma lipopolysaccharide level and an increase in short-chain fatty acids, including acetic acid, propionic acid, butyric acid and pentanoic acid, were determined after dietary FO supplementation. Correlation analysis revealed close relationships among sex steroid hormones, inflammation, and gut/vaginal microbiota. Collectively, this study demonstrated that dietary FO ameliorated PCOS through the sex steroid hormones—microbiota—inflammation axis in rats, which may contribute to the understanding of pathogenesis and potentially serve as an inexpensive intervention in the control of PCOS.

Highlights

  • Polycystic ovary syndrome (PCOS) represents a common endocrine—metabolic disorder among women of reproductive ages, with a worldwide prevalence of 4–21% [1]

  • In order to evaluate the level of sex steroid hormones in rats, plasma was obtained to determine the respective folliclestimulating hormone (FSH), luteinizing hormone (LH), E2, T, progesterone (PROG), as well as sex hormone binding globulin (SHBG), using enzyme-linked immunosorbent assay (ELISA) kits according to the manufacturers’ instructions (Shanghai Jianglai Biotech, Shanghai, China)

  • We demonstrated that the potent effects of dietary Flaxseed oil (FO) on PCOS may integrally be due to modulating the hormones–inflammation–gut/vaginal microbiota axis, potentially providing an inexpensive intervention for the control of PCOS

Read more

Summary

INTRODUCTION

Polycystic ovary syndrome (PCOS) represents a common endocrine—metabolic disorder among women of reproductive ages, with a worldwide prevalence of 4–21% [1]. Restoration of gut dysbiosis by dietary prebiotic inulin supplementation contributes to the amelioration of PCOS [23]. The role of both gut microbiota and VMB in the pathogenesis of PCOS needs to be fully elucidated. Accumulating studies have demonstrated that sex steroid hormones were closely associated with dysbacteriosis and inflammation in various metabolic disturbances [12, 28]. In addition to LPS, other metabolites (such as short-chain fatty acids, SCFAs) of the gut microbiota have been demonstrated to regulate gut homeostasis, lipid profile, insulin resistance, and inflammation [33]. Chronic inflammation might be reduced by improving the gut/vaginal microbiota dysbiosis in PCOS [21]. The present study aimed to assess the effects of dietary FO supplementation and mechanisms related to sex steroid hormones, inflammation, and gut microbiota in PCOS rats. Our study may contribute to the integral understanding of the pathogenesis of PCOS and the potential application for the control of the disease

MATERIALS AND METHODS
RESULT
DISCUSSION
CONCLUSIONS
Findings
ETHICS STATEMENT
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call